TRPV1 and cardiac hypertrophy: However, 4 weeks after TAC-induced ventricular hypertrophy, TRPV1−/− mice had significantly decreased LV ejection fraction (EF) and fractional shortening (FS) as well as significantly increased secretion of pro-inflammatory cytokines, TNFα and IL-6 [112].